Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Letters to the Editor

Primary Malignancy in Patients with Nonmelanoma Skin Cancer—Letter

William B. Grant
William B. Grant
Sunlight, Nutrition, and Health Research Center, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wbgrant@infionline.net
DOI: 10.1158/1055-9965.EPI-14-0272 Published July 2014
  • Article
  • Info & Metrics
  • PDF
Loading

The recent article by Ong and colleagues (1) reported that in England, those diagnosed with nonmelanoma skin cancer (NMSC) had a significantly increased risk of many types of internal cancers. This finding is in contrast with the finding in a previous article (2). In that article, the effects of smoking were incorporated into the analysis. It was noted in ref. (1) that the effects of body mass index, smoking, and ultraviolet (UV) exposure were not included in the analysis. In addition to smoking, diet plays an important role in the risk of many types of cancer. Dietary fat is evidently a risk factor for NMSC (3). A recent multicounty ecological study found smoking and/or diets with higher animal products and/or alcoholic beverage consumption significantly associated with most of the cancers listed in Table 2 of ref. 1 (4).

There are several reasons why the effect of UV irradiance might increase the risk of NMSC without affecting the risk of internal cancers. One is that in England, temperatures are generally low so that people generally cover most of the body surface area. Because vitamin D production is proportional to the amount of skin area exposed to UVB, vitamin D production may be low but UV irradiance on the face and arms may be high enough to cause NMSC. A second reason is that UVA (320–400 nm) can cause basal cell carcinoma without generating vitamin D. A third is that people are very conscious of the risk of NMSC from UV irradiance, so are more prone now to use sunscreen and minimize UV irradiance. In ref. 2, the years of NMSC diagnosis were from 1956 to 2000 with midpoints ranging from 1971 to 1985. There was less concern about the risk of NMSC from solar UV irradiance in those periods. An ecological study of cancer mortality rates in California found that NMSC mortality rates were significantly inversely correlated with eight types of internal cancer for males for the period 1950 to 1964 but there were no inverse correlations after that period (5). There were also no significant inverse correlations between NMSC and internal cancers for females.

Thus, the authors of ref. 1 are correct that diagnosis of NMSC for those living in England indicates increased risk of many other types of cancer. However, their study does not rule out that UVB irradiance, through production of vitamin D, can also reduce the risk of internal cancers.

See the Response, p. 1439

Disclosure of Potential Conflicts of Interest

W.B. Grant received commercial research grants from Bio-Tech Pharmacal, UV Foundation, and the Sunlight Research Forum, has honoraria from East Tennessee State University, and is a consultant/advisory board member of the Vitamin D Council.

  • Received March 11, 2014.
  • Accepted March 13, 2014.
  • ©2014 American Association for Cancer Research.

References

  1. 1.↵
    1. Ong ELH,
    2. Goldacre R,
    3. Hoang U,
    4. Sinclair R,
    5. Goldacre M
    . Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: a national record-linkage study. Cancer Epidemiol Biomarkers Prev 2014;23:490–8.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Grant WB
    . A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol 2007;103:668–74
    OpenUrlCrossRef
  3. 3.↵
    1. McNaughton SA,
    2. Marks GC,
    3. Green AC
    . Role of dietary factors in the development of basal cell cancer and squamous cell cancer of the skin. Cancer Epidemiol Biomarkers Prev 2005;14:1596–607.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Grant WB
    . A multicountry ecological study of cancer incidence rates in 2008 with respect to various risk-modifying factors. Nutrients 2013;6:163–89.
    OpenUrlPubMed
  5. 5.↵
    1. Grant WB
    . An ecological study of cancer mortality rates in California, 1950–64, with respect to solar UVB and smoking indices. Dermatoendocrinol 2012;4:176–82.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 23 (7)
July 2014
Volume 23, Issue 7
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Primary Malignancy in Patients with Nonmelanoma Skin Cancer—Letter
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Primary Malignancy in Patients with Nonmelanoma Skin Cancer—Letter
William B. Grant
Cancer Epidemiol Biomarkers Prev July 1 2014 (23) (7) 1438; DOI: 10.1158/1055-9965.EPI-14-0272

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Primary Malignancy in Patients with Nonmelanoma Skin Cancer—Letter
William B. Grant
Cancer Epidemiol Biomarkers Prev July 1 2014 (23) (7) 1438; DOI: 10.1158/1055-9965.EPI-14-0272
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Disclosure of Potential Conflicts of Interest
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Copy Number Variation and Ovarian Cancer Risk—Letter
  • Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk—Response
  • Shift Work, Chronotype, and Cancer Risk—Response
Show more Letters to the Editor
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement